Vagal nerve stimulation for treating dopamine-related conditions
Vagal nerve stimulation devices and methods are provided for treating medical conditions, such as conditions associated with insufficient dopamine and/or endogenous opioids in the brain. A device includes one or more electrodes having a contact surface for contacting an outer skin surface of a patient and an energy source coupled to the electrodes. The energy source generates one or more electrical impulses and transmits the electrical impulses to the electrodes and transcutaneously through the outer skin surface of the patient at or near a vagus nerve. The one or more electrical impulses is sufficient to modulate the vagus nerve and release dopamine and/or endogenous opioids in a brain of the patient.
1. A device for treating a medical condition in a patient, the device comprising:
one or more electrodes having a contact surface configured for contacting an outer skin surface of a patient; and
a power source coupled to the electrodes, wherein the power source is configured to generate one or more electrical impulses and to transmit the electrical impulses to the electrodes and transcutaneously through the outer skin surface of the patient at or near a vagus nerve, wherein the one or more electrical impulses is sufficient to modulate the vagus nerve to stimulate one or more dopamine-producing neurons in a brain of the patient and to produce endogenous opioids or endogenous cannabinoids within the brain of the patient.
2. The device of claim 1 further comprising a housing, wherein the power source is housed within the housing and the electrodes are coupled to the housing.
3. The device of claim 2 , wherein the one or more electrodes are housed within, or incorporated into, the housing.
4. The method of claim 1 , wherein the one or more electrical impulses is sufficient to modulate activity of the vagus nerve to release one or more inhibitory neurotransmitters within the brain of the patient.
5. The device of claim 4 , wherein the one or more inhibitory neurotransmitters comprise GABA.
6. The device of claim 1 , wherein the medical condition is addiction.
7. The device of claim 1 , further comprising a signal generator coupled to the power source, wherein the signal generator generates the one or more electrical impulses, wherein the one or more electrical pulses comprises bursts of 2 to 20 pulses within each burst, wherein each burst has a frequency of about 5 Hz to about 100 Hz.
8. The device of claim 7 , wherein each burst of pulses comprises a burst period and a constant period, wherein each burst period and constant period together have a combined frequency from about 15 Hz to about 50 Hz, and, wherein the pulses alternate between a positive voltage and a negative voltage within each of the burst periods.
9. The device of claim 7 , wherein each pulse has a duration of about 20 to about 1000 microseconds.
10. The device of claim 9 , wherein the signal generator generates zero pulses during the constant periods.
11. The device of claim 1 , wherein the outer skin surface is a neck of the patient.
12. The device of claim 1 , wherein the outer skin surface is located in or around the ear.
13. The device of claim 1 , wherein the outer skin surface is located near an auricular branch of the vagus nerve.
14. A device for treating a medical condition in a patient, the device comprising:
one or more electrodes having a contact surface configured for contacting an outer skin surface of a patient; and
a power source coupled to the electrodes, wherein the power source is configured to generate one or more electrical impulses and to transmit the electrical impulses to the electrodes and transcutaneously through the outer skin surface of the patient at or near a vagus nerve, wherein the one or more electrical impulses is sufficient to modulate the vagus nerve to release one or more inhibitory neurotransmitters within the brain of the patient and to produce endogenous opioids or endogenous cannabinoids within the brain of the patient.
15. The device of claim 14 further comprising a housing, wherein the power source is housed within the housing and the electrodes are coupled to the housing.
16. The device of claim 15 wherein the one or more electrodes are housed within, or incorporated into, the housing.
17. The device of claim 14 , wherein the one or more electrical impulses is sufficient to modulate activity of the vagus nerve to stimulate one or more dopamine-producing neurons in the brain of the patient.
18. The device of claim 14 , wherein the one or more inhibitory neurotransmitters comprise GABA.
19. The device of claim 14 , wherein the medical condition is addiction.
20. The device of claim 14 , further comprising a signal generator coupled to the power source, wherein the signal generator generates the one or more electrical impulses, wherein the one or more electrical pulses comprises bursts of 2 to 20 pulses within each burst, wherein each burst has a frequency of about 5 Hz to about 100 Hz.
21. The device of claim 20 , wherein each burst of pulses comprises a burst period and a constant period, wherein each burst period and constant period together have a combined frequency from about 15 Hz to about 50 Hz, and, wherein the pulses alternate between a positive voltage and a negative voltage within each of the burst periods.
22. The device of claim 21 , wherein the signal generator generates zero pulses during the constant periods.
23. The device of claim 20 , wherein each pulse has a duration of about 20 to about 1000 microseconds.
24. The device of claim 14 , wherein the outer skin surface is a neck of the patient.
25. The device of claim 14 , wherein the outer skin surface is located in or around the ear.
26. The device of claim 14 , wherein the outer skin surface is located near an auricular branch of the vagus nerve.